UTHR UNITED THERAPEUTICS Corp: institutional ownership and insider trading
948 funds reported holding $26.6B of UNITED THERAPEUTICS Corp in their latest 13F filings; in Q2 2026 funds net sold $713M, with 97 new positions and 73 funds selling out; over the last 12 months insiders bought $0 and sold $1.44B on the open market.
Famous investors holding UTHR
- Renaissance Technologies (Renaissance Technologies): $926M, 1.3% of the portfolio
- Ray Dalio (Bridgewater Associates): $60.3M, 0.3% of the portfolio
- Izzy Englander (Millennium Management): $263M, 0.1% of the portfolio
- Ken Griffin (Citadel Advisors): $405M, 0.1% of the portfolio
- Two Sigma (Two Sigma Investments): $6.83M, 0.0% of the portfolio
Largest institutional holders of UTHR
- BlackRock, Inc. (BLK) — $2.87B
- VANGUARD GROUP INC — $2.03B
- Avoro Capital Advisors LLC — $1.51B
- VANGUARD PORTFOLIO MANAGEMENT LLC — $1.04B
- VANGUARD CAPITAL MANAGEMENT LLC — $1.04B
- STATE STREET CORP (STT, STT-PG) — $1.03B
- RENAISSANCE TECHNOLOGIES LLC — $926M
- WELLINGTON MANAGEMENT GROUP LLP — $747M
- GEODE CAPITAL MANAGEMENT, LLC — $539M
- JANUS HENDERSON GROUP PLC (JHG) — $514M
Recent UTHR insider trades
- Oct 22, 2026: Rothblatt Martine A sold 9,500 shares ($5.54M)
- Oct 21, 2026: Rothblatt Martine A sold 9,500 shares ($5.32M)
- Oct 20, 2026: Rothblatt Martine A sold 9,500 shares ($5.26M)
- Oct 19, 2026: Rothblatt Martine A sold 9,500 shares ($5.16M)
Members of Congress trading UTHR
- Oct 31, 2025: Lisa C. McClain sold $1.00K–$15.0K
- Oct 30, 2025: Lisa C. McClain sold $1.00K–$15.0K
- Oct 30, 2025: Lisa C. McClain bought $1.00K–$15.0K
- Jun 11, 2025: Lisa C. McClain bought $1.00K–$15.0K
5%+ owners
- ROTHBLATT MARTINE A: 5.3% (Schedule 13G/A, filed Aug 14, 2026)
- Vanguard Capital Management: 5.2% (Schedule 13G, filed Apr 30, 2026)